Trulicity vs Lyxumia

Quick Facts

  • Type: GLP-1
  • FDA Approval: Trulicity (2014), Lyxumia (2016)
  • Frequency: Once weekly

Weight Loss Data

  • Trulicity: 2-6% in 52 weeks
  • Lyxumia: 2-4% in 24 weeks

Primary Uses

  • Type 2 Diabetes
  • Cardiovascular Risk Reduction

Medication Overview

Trulicity

GLP-1

Basic Information

  • Generic Name: dulaglutide
  • Manufacturer: Eli Lilly
  • FDA Approval: 2014

Key Benefits

  • Once-weekly dosing
  • Ready-to-use pen
  • Cardiovascular benefits
  • No dose titration required for standard dose

Lyxumia

GLP-1

Basic Information

  • Generic Name: lixisenatide
  • Manufacturer: Sanofi
  • FDA Approval: 2016

Key Benefits

  • Once-daily dosing
  • Reduces post-meal glucose levels
  • Simple titration schedule
  • Can be used with basal insulin

Dosing Information

Dosing DetailsTrulicityLyxumia
Starting Dose0.75mg10mcg
Maintenance Dose1.5mg20mcg
Maximum Dose4.5mg20mcg
ScheduleInject once weekly at any time of dayInject once daily within one hour before the first meal of the day
TitrationStart with 0.75mg, can increase to 1.5mg after 4 weeks if neededStart with 10mcg daily for 14 days, then increase to 20mcg daily

Side Effects

Trulicity

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal Pain
  • Decreased Appetite
  • Indigestion

Lyxumia

  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Dizziness
  • Injection Site Reactions

Practical Information

Trulicity

Storage & Handling

  • Storage: Refrigerate until first use, then can be stored at room temperature for up to 14 days
  • Needle Info: Comes with attached hidden needle

Insurance & Coverage

Generally well-covered for diabetes treatment

Clinical Results

  • Weight Loss: 2-6%
  • Study Duration: 52 weeks
  • Study: AWARD clinical trial program

Lyxumia

Storage & Handling

  • Storage: Refrigerate until first use, then can be stored at room temperature for up to 14 days
  • Needle Info: Requires separate pen needles

Insurance & Coverage

Coverage varies by region and insurance plan

Clinical Results

  • Weight Loss: 2-4%
  • Study Duration: 24 weeks
  • Study: GetGoal clinical trial program

Medical Disclaimer: This comparison is for informational purposes only and should not replace professional medical advice. Always consult with your healthcare provider about which medication is right for you. Treatment decisions should be based on your individual medical needs and circumstances.

ShotWise App Interface

Track Your GLP-1 Journey with ShotWise

Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.

Download ShotWise